company background image
CVRX logo

CVRx NasdaqGS:CVRX Stock Report

Last Price

US$14.85

Market Cap

US$360.3m

7D

6.8%

1Y

-25.8%

Updated

24 Nov, 2024

Data

Company Financials +

CVRx, Inc.

NasdaqGS:CVRX Stock Report

Market Cap: US$360.3m

CVRX Stock Overview

A commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. More details

CVRX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Revenue is forecast to grow 22.08% per year

Risk Analysis

Currently unprofitable and not forecast to become profitable over the next 3 years

Shareholders have been diluted in the past year

Volatile share price over the past 3 months compared to the US market


CVRx, Inc. Competitors

Delcath Systems

NasdaqCM:DCTH

US$312.1m

Treace Medical Concepts

NasdaqGS:TMCI

US$487.8m

ClearPoint Neuro

NasdaqCM:CLPT

US$326.5m

Tactile Systems Technology

NasdaqGM:TCMD

US$428.3m

Price History & Performance

Summary of all time highs, changes and price drops for CVRx
Historical stock prices
Current Share PriceUS$14.85
52 Week HighUS$33.14
52 Week LowUS$6.40
Beta1.11
11 Month Change47.47%
3 Month Change48.50%
1 Year Change-25.82%
33 Year Change14.67%
5 Year Changen/a
Change since IPO-46.96%

Recent News & Updates

CVRx: Impressive Top-Line Growth Seems Priced In

Nov 07

Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Third-Quarter Report

Nov 01
Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Third-Quarter Report

Investors Still Waiting For A Pull Back In CVRx, Inc. (NASDAQ:CVRX)

Oct 10
Investors Still Waiting For A Pull Back In CVRx, Inc. (NASDAQ:CVRX)

Recent updates

CVRx: Impressive Top-Line Growth Seems Priced In

Nov 07

Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Third-Quarter Report

Nov 01
Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Third-Quarter Report

Investors Still Waiting For A Pull Back In CVRx, Inc. (NASDAQ:CVRX)

Oct 10
Investors Still Waiting For A Pull Back In CVRx, Inc. (NASDAQ:CVRX)

Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Jul 31
Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By CVRx, Inc.'s (NASDAQ:CVRX) 32% Share Price Surge

Jun 18
Why Investors Shouldn't Be Surprised By CVRx, Inc.'s (NASDAQ:CVRX) 32% Share Price Surge

The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 47%

May 04
The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 47%

Rock star Growth Puts CVRx (NASDAQ:CVRX) In A Position To Use Debt

Apr 10
Rock star Growth Puts CVRx (NASDAQ:CVRX) In A Position To Use Debt

The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 25%

Feb 29
The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 25%

Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 34%

Nov 11
Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 34%

Companies Like CVRx (NASDAQ:CVRX) Are In A Position To Invest In Growth

Aug 20
Companies Like CVRx (NASDAQ:CVRX) Are In A Position To Invest In Growth

CVRx Pursues Revenue Growth But Operating Losses Worsen

Aug 05

CVRx: Barostim Story Looks Well Priced In, Overvalued At Just 5x Sales

Jun 21

We Think CVRx (NASDAQ:CVRX) Can Afford To Drive Business Growth

Apr 12
We Think CVRx (NASDAQ:CVRX) Can Afford To Drive Business Growth

Earnings Release: Here's Why Analysts Cut Their CVRx, Inc. (NASDAQ:CVRX) Price Target To US$20.33

Feb 18
Earnings Release: Here's Why Analysts Cut Their CVRx, Inc. (NASDAQ:CVRX) Price Target To US$20.33

CVRx: The Path To 7x Investment Returns

Jan 07

Shareholder Returns

CVRXUS Medical EquipmentUS Market
7D6.8%1.5%2.2%
1Y-25.8%20.8%31.6%

Return vs Industry: CVRX underperformed the US Medical Equipment industry which returned 20.9% over the past year.

Return vs Market: CVRX underperformed the US Market which returned 31.7% over the past year.

Price Volatility

Is CVRX's price volatile compared to industry and market?
CVRX volatility
CVRX Average Weekly Movement14.3%
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.3%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Stable Share Price: CVRX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: CVRX's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2000200Kevin Hykeswww.cvrx.com

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally.

CVRx, Inc. Fundamentals Summary

How do CVRx's earnings and revenue compare to its market cap?
CVRX fundamental statistics
Market capUS$360.32m
Earnings (TTM)-US$58.48m
Revenue (TTM)US$47.26m

7.6x

P/S Ratio

-6.2x

P/E Ratio

Is CVRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CVRX income statement (TTM)
RevenueUS$47.26m
Cost of RevenueUS$7.48m
Gross ProfitUS$39.77m
Other ExpensesUS$98.25m
Earnings-US$58.48m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-2.41
Gross Margin84.16%
Net Profit Margin-123.75%
Debt/Equity Ratio75.5%

How did CVRX perform over the long term?

See historical performance and comparison